Cirrhosis with COVID-19: Just Another Infection or Something More to It?

Overview

Journal JGH Open

Specialty Gastroenterology

Date 2024 Jan 1

PMID 38162849

Authors

Dibyalochan Praharaj

Madhumita Premkumar

Affiliations

Soon will be listed here.

References

Bajaj J, Kamath P, Reddy K . The Evolving Challenge of Infections in Cirrhosis. N Engl J Med. 2021; 384(24):2317-2330. DOI: 10.1056/NEJMra2021808. View

Brozat J, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L . COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterol J. 2022; 10(4):409-424. PMC: 9103364. DOI: 10.1002/ueg2.12232. View

Ekpanyapong S, Reddy K . Infections in Cirrhosis. Curr Treat Options Gastroenterol. 2019; 17(2):254-270. PMC: 7101776. DOI: 10.1007/s11938-019-00229-2. View

Kulkarni A, Tevethia H, Premkumar M, Arab J, Candia R, Kumar K . Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. EClinicalMedicine. 2021; 38:101025. PMC: 8276632. DOI: 10.1016/j.eclinm.2021.101025. View

Bajaj J, Garcia-Tsao G, Biggins S, Kamath P, Wong F, McGeorge S . Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2020; 70(3):531-536. PMC: 7371484. DOI: 10.1136/gutjnl-2020-322118. View

Sarin S, Choudhury A, Lau G, Zheng M, Ji D, Abd-Elsalam S . Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020; 14(5):690-700. PMC: 7334898. DOI: 10.1007/s12072-020-10072-8. View

Sohail A, Naseem K, Khan A, Adhami T, Brown K . Predictors of inpatient outcomes of COVID-19 infection in patients with cirrhosis in the early pandemic phase: A nationwide survey. JGH Open. 2024; 7(12):889-898. PMC: 10757488. DOI: 10.1002/jgh3.12998. View

Premkumar M, Kedarisetty C . Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol. 2021; 9(2):256-264. PMC: 8111101. DOI: 10.14218/JCTH.2021.00055. View

Iavarone M, DAmbrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P . High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020; 73(5):1063-1071. PMC: 7280108. DOI: 10.1016/j.jhep.2020.06.001. View

10.

Marjot T, Moon A, Cook J, Abd-Elsalam S, Aloman C, Armstrong M . Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2020; 74(3):567-577. PMC: 7536538. DOI: 10.1016/j.jhep.2020.09.024. View